2 year study of AxSpA pts in clinical remission who tapered TNFi.
⭐️52% successfully tapered to either 2/3, 1/2 or 1/3 dose
⭐️Baseline physician global score independent predictor of successful tapering
Abs#364
#ACR21
@RheumNow
https://t.co/9Kti5JGMYr https://t.co/y1Uj2dTABC
Links:
Dose Tapering of TNF Inhibitors in Patients with Axial Spondyloarthritis in Rou…
https://bit.ly/3BR2giY
06-11-2021